Trial
NCT02939365
Precision Medicine Offers Belatacept Monotherapy
Phase IVWITHDRAWNREGULATORYConfidence: HIGH
Sponsor
University of California, San Francisco
Collaborators
Bristol-Myers Squibb
Condition
Transplantation
Intervention
Belatacept
Why stopped
Because of inability to get FDA approval for
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-12-06